FDA Inspection 1042820 — Mazen M. Dimachkie, MD

Mazen M. Dimachkie, MD — FEI 3014109843

The FDA completed an inspection of Mazen M. Dimachkie, MD on Mar 2, 2018 in Kansas City, KS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 2, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Kansas City, KS (United States)

Additional Details

Sponsor-Investigator (S-I)

Citations

IDCFRDescription
755421 CFR 312.53(c)(4)Financial information - sufficient and accurate
756021 CFR 312.60FD-1572, protocol compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.